Business Description
![hVIVO PLC hVIVO PLC logo](https://static.gurufocus.com/logos/0C00009SQU.png?14)
hVIVO PLC
ISIN : GB00B9275X97
Compare
Compare
Traded in other countries / regions
HVO.UKCRO.GermanyHVO.IrelandOPORF.USA IPO Date
2017-04-11Description
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.95 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | 0.89 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.29 | |||||
Beneish M-Score | -1.63 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 34.1 | |||||
3-Year FCF Growth Rate | 53.3 | |||||
3-Year Book Growth Rate | 14.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 10.12 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.78 | |||||
9-Day RSI | 47.94 | |||||
14-Day RSI | 48.97 | |||||
6-1 Month Momentum % | 21.74 | |||||
12-1 Month Momentum % | 87.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.48 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 1.05 | |||||
Days Inventory | 6.89 | |||||
Days Sales Outstanding | 47.21 | |||||
Days Payable | 30.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.81 | |||||
Forward Dividend Yield % | 0.81 | |||||
5-Year Yield-on-Cost % | 0.81 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | -2.47 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.87 | |||||
Operating Margin % | 18.42 | |||||
Net Margin % | 28.76 | |||||
FCF Margin % | 21.53 | |||||
ROE % | 63.45 | |||||
ROA % | 25.97 | |||||
ROIC % | 33.4 | |||||
ROC (Joel Greenblatt) % | 125.41 | |||||
ROCE % | 36.59 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 11.38 | |||||
Forward PE Ratio | 21.01 | |||||
PE Ratio without NRI | 21 | |||||
Price-to-Owner-Earnings | 8.53 | |||||
PS Ratio | 3.33 | |||||
PB Ratio | 5.46 | |||||
Price-to-Tangible-Book | 7.15 | |||||
Price-to-Free-Cash-Flow | 16.06 | |||||
Price-to-Operating-Cash-Flow | 10.92 | |||||
EV-to-EBIT | 14.06 | |||||
EV-to-Forward-EBIT | 15.58 | |||||
EV-to-EBITDA | 11.34 | |||||
EV-to-Forward-EBITDA | 11.69 | |||||
EV-to-Revenue | 2.84 | |||||
EV-to-Forward-Revenue | 2.6 | |||||
EV-to-FCF | 13.37 | |||||
Price-to-Projected-FCF | 3.18 | |||||
Price-to-Median-PS-Value | 1.91 | |||||
Price-to-Graham-Number | 2.38 | |||||
Earnings Yield (Greenblatt) % | 7.12 | |||||
FCF Yield % | 6.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
hVIVO PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 65.179 | ||
EPS (TTM) (€) | 0.028 | ||
Beta | 1.77 | ||
Volatility % | 41.27 | ||
14-Day RSI | 48.97 | ||
14-Day ATR (€) | 0.002808 | ||
20-Day SMA (€) | 0.2849 | ||
12-1 Month Momentum % | 87.92 | ||
52-Week Range (€) | 0.146 - 0.368 | ||
Shares Outstanding (Mil) | 680.37 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
hVIVO PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
hVIVO PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
hVIVO PLC Frequently Asked Questions
What is hVIVO PLC(STU:CRO)'s stock price today?
The current price of STU:CRO is €0.29. The 52 week high of STU:CRO is €0.37 and 52 week low is €0.15.
When is next earnings date of hVIVO PLC(STU:CRO)?
The next earnings date of hVIVO PLC(STU:CRO) is 2024-09-12 Est..
Does hVIVO PLC(STU:CRO) pay dividends? If so, how much?
The Dividend Yield %  of hVIVO PLC(STU:CRO) is 0.81% (As of Today), Highest Dividend Payout Ratio of hVIVO PLC(STU:CRO) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of hVIVO PLC(STU:CRO) is 0.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |